前列腺癌基金会首席执行官主张在新西兰实施640万美元的PSA血液检测方案,声称该方案可以将前列腺癌死亡率减半,并改进早期检测。 Prostate Cancer Foundation CEO advocates $6.4m PSA blood test screening program in NZ, claiming it could halve prostate cancer deaths and improve early detection.
前列腺癌基金会首席执行官彼得·狄更斯主张在新西兰实施PSA血液测试方案,声称该方案可以将前列腺癌死亡减半。 Prostate Cancer Foundation CEO Peter Dickens advocates for a PSA blood test screening program in New Zealand, claiming it could halve prostate cancer deaths. 基金会寻求政府资助两个试点项目,费用为640万美元,重点是年龄和遗传风险。 The foundation seeks government funding for two pilots costing $6.4 million, focusing on age and genetic risk. 此外,最近的研究表明,用MRI向的活检可以显著减少低级癌症的过度诊断. Additionally, recent studies suggest MRI-targeted biopsies can significantly reduce overdiagnosis of low-grade cancers. 这种办法可以加强早期发现,同时尽量减少不必要的治疗。 This approach could enhance early detection while minimizing unnecessary treatments.